EQUITY•SECTORAL / THEMATIC
Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment
3 Year return
18.76%
NAV on August 11, 2026
642.5969
1D Returns
+0.61%
Launched on January 2013(13 years)
Investment Details
N/A
Minimum SIP Amount
₹5000
Minimum one time investment
Fund has no lock-in period
Calculate Returns
Based on past performance of this fund
₹
Your Investment₹3,600
Gain
34.97%₹1,259
Total Value ₹4,859
Risk Involved
Your principal will be at
Very High Risk
Scheme Information
Asset Under Management
₹9,044.23 Cr.
Expense Ratio
1% (inclusive of GST)
Exit Load
1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
Ratings
0
Ratings by other agencies
Value Research
0
Crisil
0
Morning Star
0
Tax Implications
Withdrawal within 1 year:
20% tax on gains
Withdrawal after 1 year:
12.5% tax on gains above ₹1.25 lakh per financial year
Nippon India Mutual Fund Manager
AS
Akshay Sharma
Fund Manager since Dec 2022
AS
Amber Singhania
Fund Manager since Mar 2026
DD
Divya Dutt Sharma
Fund Manager since Sep 2025
KD
Kinjal Desai
Fund Manager since Mar 2026
LM
Lokesh Maru
Fund Manager since Sep 2025
SR
Sailesh Raj Bhan
Fund Manager since Jun 2007
Fund House Details
Nippon India Mutual Fund
Asset management company
AUM
₹7,67,506.42 Cr.
No. of Schemes
335
Setup Date
June 1995
Peer Comparison
Comparison with other similar funds
| Funds | 3 Y Returns | ARQ Rating |
|---|---|---|
| Aditya Birla Sun Life PSU Equity Fund | 24.7224% | 0 |
| SBI PSU Fund | 25.2643% | 0 |
| LIC MF Infrastructure Fund | 26.704% | 0 |
Schemes by Nippon India Mutual Fund
List of mutual fund schemes by AMC
Funds
3 Years Returns
Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is managed by Nippon Life India Asset Management Limited, formerly known as Reliance Nippon Life Asset Management Limited. Categorised as Sectoral/Thematic Funds, this fund focuses on investing in companies within a specific sector or theme, in this case, the pharmaceutical sector. Sectoral funds like this one concentrate on specific industries, aiming to benefit from the growth potential of that sector. Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is an open-ended fund, meaning investors can buy or sell units of the fund at any time, within market hours.
Investment Objective of the Scheme
The primary investment objective of the Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is to seek long-term capital appreciation by primarily investing in equity and equity-related securities of companies in the pharmaceutical sector.
Key Features of The Fund
5-year return
13.7606%
Expense Ratio
1%
Fund Manager
Akshay Sharma
Fund Size
₹9044.23 Cr.
Risk Profile
Very High
Is This Scheme Right for Me?
This fund might be suitable for investors who have a positive outlook on the pharmaceutical sector and want to allocate a portion of their funds to this specific industry. Sectoral funds can offer higher potential returns but also come with concentrated risk. So, investors with low-risk tolerance should not consider this fund. Interested investors should also bear in mind the potential volatility of the pharmaceutical sector before making a decision.
AMC Contact Details
| Name | Nippon India Mutual Fund |
| Launch Date | June 1995 |
| Address | Nippon Life India Asset Management Limited, 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai – 400 013 |
| Contact | 1860 266 0111 |
| customercare@nipponindiaim.in | |
| Website | https://mf.nipponindiaim.com/ |
Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.
Invest Smart, Start Your SIP Today
Take control of your financial future by using our systematic investment plan calculator. All you have to do is input your desired investment amount and time horizon into our SIP calculator. Witness firsthand the potential growth of your investments as you tailor your strategy to match your unique financial objectives. With a personalised approach, you can ensure steady wealth accumulation over time, bringing you closer to your financial goals.
FAQs
What is today's NAV of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
NAV, or Net Asset Value, is the price of a single unit of a mutual fund. It is calculated by dividing the current value of holdings held by the mutual fund scheme at the end of the day by the total number of units issued. The NAV changes every day. The NAV of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment on August 11, 2026, is ₹642.5969
What is the AUM of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
Short for Asset Under Management, AUM means the total assets held by a mutual fund scheme. The AUM of the fund changes every day based on the fluctuation in the price of the underlying assets. Fund houses don't update AUM on a daily basis. They only update it at the end of the month and release it within a few days of the following month. The AUM of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment, is ₹9044.23 crore.
What is the expense ratio of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
The expense ratio is the annual charges you pay to the mutual fund house for managing your investments. It is a percentage of Assets Under Management. It is deducted from the fund's returns. The expense ratio of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment is 1%
What are the returns of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment since inception?
The Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment was launched on January 01, 2013. The fund has delivered a CAGR of undefined since inception.
What is the minimum SIP amount to invest in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
A Systematic Investment Plan (SIP) in mutual funds allows you to invest small amounts periodically instead of a one-time investment. The frequency of investment can be monthly, quarterly, half-yearly or annually, as per your convenience. The minimum SIP for Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment is ₹0.
How do I invest in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
- Make sure you are logged in to Angel One.
- Select the type of investment: SIP or one-time.
- In case of an SIP, select the amount and date and click ‘Start SIP’. In case of a one-time investment, enter just the amount.
- Proceed by clicking the pay button and choosing your mode of payment.
- Your portfolio will be updated with this investment in 3-5 working days.
How to start an SIP in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
- Click on the ‘Invest’ button.
- Enter your desired SIP amount and the SIP date.
- You can uncheck the ‘Make first payment now’ box if you don’t want to make the payment right away.
- Choose your payment method between UPI and Net Banking.
- Make your payment.
- Your SIP is created.
How do I automate an SIP in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
- Once you create an SIP, click on ‘Set up autopay’
- Select your desired verification method - debit card, net banking or Aadhar method credentials - and click on submit.
- Once you verify the OTP, your mandate request will be created.
How can I withdraw/redeem my investment in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
- Go to the ‘Investments’ section and click on the mutual fund scheme you want to withdraw.
- Enter the amount you want to withdraw and tap the ‘Withdraw’ button.
- Verify the details on the ‘Confirm withdraw’ screen.
- Select the bank account in which you want to receive the funds.
- You will receive your funds within three working days of placing the order.
- You can track your order in the ‘Orders’ section.
ENTER AMOUNT
₹
₹4,859 in 3Y at 18.7576% returns
SIP Date1st of every month
Your next SIP Payment will be on 11 September 2026
By proceeding, you accept AngelOne's T&C
